- Home
- Publications
- Publication Search
- Publication Details
Title
New drug on the horizon for treating adenovirus
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 14, Pages 2095-2099
Publisher
Informa Healthcare
Online
2016-02-13
DOI
10.1517/14656566.2015.1083975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of Cidofovir on Adenovirus Plasma DNA Levels in Stem Cell Transplantation Recipients without T Cell Reconstitution
- (2015) Gertjan Lugthart et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT
- (2015) J. Feucht et al. BLOOD
- Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters
- (2015) Karoly Toth et al. Viruses-Basel
- Ganciclovir Inhibits Human Adenovirus Replication and Pathogenicity in Permissive Immunosuppressed Syrian Hamsters
- (2014) Baoling Ying et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model
- (2014) Ann E. Tollefson et al. ANTIVIRAL RESEARCH
- Adenovirus Infections in Immunocompetent and Immunocompromised Patients
- (2014) T. Lion CLINICAL MICROBIOLOGY REVIEWS
- Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses
- (2014) Diana F Florescu et al. Expert Review of Anti-Infective Therapy
- Antiviral T-cell therapy
- (2014) Ann M. Leen et al. IMMUNOLOGICAL REVIEWS
- Adenovirus: Current Epidemiology and Emerging Approaches to Prevention and Treatment
- (2014) Uriel Sandkovsky et al. Current Infectious Disease Reports
- Short-Term In-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application
- (2013) René Geyeregger et al. PLoS One
- Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients
- (2011) Diana F. Florescu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001
- (2010) Kris Paolino et al. JOURNAL OF CLINICAL VIROLOGY
- Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation
- (2010) T Lion et al. LEUKEMIA
- Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model
- (2008) K. Toth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More